Print

Print


One Step Closer To An Artificial Nerve Cell
Article Date: 08 Jul 2009 - 6:00 PDT

Scientists at the Swedish medical university Karolinska Institutet and 
Linköping University are well on the way to creating the first artificial 
nerve cell that can communicate specifically with nerve cells in the body 
using neurotransmitters. The technology has been published in an article in 
Nature Materials.

The methods that are currently used to stimulate nerve signals in the 
nervous system are based on electrical stimulation. Examples of this are 
cochlear implants, which are surgically inserted into the cochlea in the 
inner ear, and electrodes that are used directly in the brain. One problem 
with this method is that all cell types in the vicinity of the electrode are 
activated, which gives undesired effects.

Scientists have now used an electrically conducting plastic to create a new 
type of "delivery electrode" that instead releases the neurotransmitters 
that brain cells use to communicate naturally. The advantage of this is that 
only neighbouring cells that have receptors for the specific 
neurotransmitter, and that are thus sensitive to this substance, will be 
activated.

The scientists demonstrate in the article in Nature Materials that the 
delivery electrode can be used to control the hearing function in the brains 
of guinea pigs.

"The ability to deliver exact doses of neurotransmitters opens completely 
new possibilities for correcting the signalling systems that are faulty in a 
number of neurological disease conditions", says Professor Agneta 
Richter-Dahlfors who has led the work, together with Professor Barbara 
Canlon.

The scientists intend to continue with the development of a small unit that 
can be implanted into the body. It will be possible to program the unit such 
that the release of neurotransmitters takes place as often or as seldom as 
required in order to treat the individual patient. Research projects that 
are already under way are targeted towards hearing, epilepsy and Parkinson's 
disease.

The research is being carried out in collaboration between the research 
groups of Professor Agneta Richter-Dahlfors and Professor Barbara Canlon, 
together with Professor Magnus Berggren's group at Linköping University. The 
work falls under the auspices of the Center of Excellence in Organic 
Bioelectronics, financed by the Swedish Foundation for Strategic Research 
and led by Magnus Berggren and Agneta Richter-Dahlfors.

Publication: "Organic electronics for precise delivery of neurotransmitters 
to modulate mammalian sensory function", Daniel T. Simon, Sindhulakshmi 
Kurup, Karin C. Larsson, Ryusuke Hori, Klas Tybrandt, Michel Goiny, Edwin W. 
H. Jager, Magnus Berggren, Barbara Canlon and Agneta Richter-Dahlfors, 
Nature Materials, Advance Online Publication, 5 June 2009.

Source:
Sabina Bossi
Karolinska Institutet

 Rayilyn Brown
Director AZNPF
Arizona Chapter National Parkinson Foundation
[log in to unmask] 

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn